# BioAegis Therapeutics, Inc. — Form D

BioAegis Therapeutics, Inc. of Morristown, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2016-03-14. The offering totals $5.0M, of which $1.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2016-03-14
- Form: D
- Accession: 0001546604-16-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.5M
- Remaining: $3.5M
- Investors: 1
- Date of first sale: 2016-02-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-259147

## Issuer

- Name: BioAegis Therapeutics, Inc.
- CIK: 0001546604
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 6 East Cove Lane, Morristown, NJ, 07960
- Phone: 973-539-4552

## Officers, directors & promoters (17)

| Name | Role | Location |
| --- | --- | --- |
| Steven Cordovano | Executive Officer | North Brunswick, NJ |
| Valerie Ceva | Director | Morristown, NJ |
| Valerie Ceva | Executive Officer | Morristown, NJ |
| Mark DiNubile | Director | Morristown, NJ |
| Mark DiNubile | Executive Officer | Morristown, NJ |
| Susan Levinson | Director | Morristown, NJ |
| Susan Levinson | Executive Officer | Morristown, NJ |
| John Stossel | Director | Morristown, NJ |
| Thomas Stossel | Director | North Brunswick, NJ |
| Thomas Stossel | Executive Officer | North Brunswick, NJ |
| Steve Cordovano | Executive Officer | Morristown, NJ |
| Susan L Levinson | Director | Morristown, NJ |
| Susan L Levinson | Executive Officer | Morristown, NJ |
| Valerie L Ceva | Director | New York, NY |
| Valerie L Ceva | Executive Officer | New York, NY |
| Thomas L Stossel | Director | Belmont, MA |
| Steven L Cordovano | Executive Officer | Rowayton, CT |

## Other filings by this issuer (8)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-05-11](https://search.stillhousedata.com/formd/0001546604-22-000001) | D | $21.8M | $21.8M |
| [2020-10-07](https://search.stillhousedata.com/formd/0001546604-20-000002) | D/A | $7.0M | $7.0M |
| [2020-06-17](https://search.stillhousedata.com/formd/0001546604-20-000001) | D | $5.0M | $5.0M |
| [2018-09-26](https://search.stillhousedata.com/formd/0001546604-18-000003) | D | $7.0M | $4.1M |
| [2015-04-17](https://search.stillhousedata.com/formd/0001546604-15-000001) | D/A | — | $8.0M |
| [2014-02-07](https://search.stillhousedata.com/formd/0001546604-14-000001) | D/A | $6.0M | $3.7M |
| [2013-02-08](https://search.stillhousedata.com/formd/0001546604-13-000001) | D/A | $6.0M | $3.1M |
| [2012-04-11](https://search.stillhousedata.com/formd/0001546604-12-000002) | D | $6.0M | $497K |

## More

- [CIK 1546604 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1546604&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001546604-16-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.